Medidata Solutions Inc (MDSO) Analysts See $0.17 EPS

July 18, 2017 - By Winifred Garcia

 Medidata Solutions Inc (MDSO) Analysts See $0.17 EPS
Investors sentiment increased to 1.1 in Q4 2016. Its up 0.09, from 1.01 in 2016Q3. It improved, as 28 investors sold Medidata Solutions Inc shares while 63 reduced holdings. 32 funds opened positions while 68 raised stakes. 56.66 million shares or 0.52% less from 56.95 million shares in 2016Q3 were reported.
Moreover, Cap Fund Sa has 0.01% invested in Medidata Solutions Inc (NASDAQ:MDSO) for 25,100 shares. American Century holds 316,366 shares or 0.02% of its portfolio. Sg Americas Limited Liability Company, New York-based fund reported 5,066 shares. Hsbc Holdings Public Ltd invested 0% of its portfolio in Medidata Solutions Inc (NASDAQ:MDSO). Cap Impact Advsr Ltd Co has 25,805 shares. Tiedemann Wealth Ltd Liability holds 0.05% or 10,725 shares in its portfolio. 7,200 are held by Tocqueville Asset Management Lp. State Board Of Administration Of Florida Retirement has invested 0.01% in Medidata Solutions Inc (NASDAQ:MDSO). Geode Cap Mngmt Limited Liability Corporation invested in 0.01% or 430,537 shares. Profund Advsr Ltd Liability owns 0.02% invested in Medidata Solutions Inc (NASDAQ:MDSO) for 10,932 shares. Mycio Wealth Prtnrs reported 12,011 shares. The Wisconsin-based State Of Wisconsin Invest Board has invested 0.01% in Medidata Solutions Inc (NASDAQ:MDSO). Synovus Corp has 0% invested in Medidata Solutions Inc (NASDAQ:MDSO). Pier Cap Ltd Liability Com accumulated 0.93% or 103,341 shares. Conestoga Advisors Ltd Liability Corp owns 1.61% invested in Medidata Solutions Inc (NASDAQ:MDSO) for 486,000 shares.

Since January 25, 2017, it had 0 buys, and 9 sales for $3.63 million activity. Otner Michael I. had sold 10,000 shares worth $559,200 on Thursday, February 16. $420,375 worth of stock was sold by de Vries Glen Michael on Thursday, March 9. The insider Capone Michael L sold $347,300. Sherif Tarek had sold 2,964 shares worth $169,185 on Tuesday, April 4. Another trade for 10,000 shares valued at $508,300 was made by Hirschfeld Steven Isaac on Wednesday, January 25.

Wall Street await Medidata Solutions Inc (NASDAQ:MDSO) to release earnings on July, 19. Analysts forecast EPS of $0.17, up exactly $0.04 or 30.77 % from 2014’s $0.13 EPS. The expected MDSO’s profit could reach $10.05M giving the stock 119.12 P/E in the case that $0.17 earnings per share is reported. After posting $0.20 EPS for the previous quarter, Medidata Solutions Inc’s analysts now forecast -15.00 % negative EPS growth. The stock decreased 0.94% or $0.77 during the last trading session, reaching $81. About shares traded. Medidata Solutions Inc (NASDAQ:MDSO) has risen 68.37% since July 18, 2016 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions Inc (NASDAQ:MDSO) Ratings Coverage

Among 14 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Medidata Solutions Inc. had 22 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Wells Fargo on Thursday, July 21 to “Market Perform”. The stock of Medidata Solutions Inc (NASDAQ:MDSO) earned “Overweight” rating by KeyBanc Capital Markets on Wednesday, September 9. The rating was downgraded by Jefferies to “Underperform” on Tuesday, April 26. The firm has “Buy” rating by Deutsche Bank given on Tuesday, September 13. The stock has “Buy” rating by Morgan Stanley on Wednesday, June 14. Needham maintained the stock with “Buy” rating in Friday, February 10 report. The stock of Medidata Solutions Inc (NASDAQ:MDSO) has “Market Perform” rating given on Tuesday, April 26 by Leerink Swann. Needham maintained the shares of MDSO in report on Thursday, February 11 with “Buy” rating. The firm has “Buy” rating given on Wednesday, October 28 by Topeka Capital Markets. Jefferies maintained the stock with “Hold” rating in Friday, June 16 report.

Medidata Solutions Inc. is a well-known provider of cloud solutions for life sciences. The company has market cap of $4.79 billion. The Firm provides cloud solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. It has a 142.58 P/E ratio. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

More important recent Medidata Solutions Inc (NASDAQ:MDSO) news were published by: Streetinsider.com which released: “Medidata Solutions (MDSO) to Join S&P MidCap 400; McDermott International (MDR …” on June 20, 2017, also Businesswire.com published article titled: “Medidata Reports Record Second Quarter 2017 Results”, Nasdaq.com published: “Medidata (MDSO), inVentiv Enter Into Multi-Year Partnership” on June 27, 2017. More interesting news about Medidata Solutions Inc (NASDAQ:MDSO) was released by: Nasdaq.com and their article: “Medidata Solutions (MDSO) Set to Join the S&P 400 Index” with publication date: June 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.